Kiniksa Pharmaceuticals International, plc
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | — | — | $56.1M |
| FY2017 | $17.4M | $47.5M | $45.6M |
| FY2018 | $42.7M | $322.0M | $72.0M |
| FY2019 | $29.1M | $254.5M | $46.9M |
| FY2020 | $37.5M | $349.5M | $114.0M |
| FY2021 | $47.8M | $232.8M | $122.5M |
| FY2022 | $63.5M | $459.7M | $122.7M |
| FY2023 | $87.5M | $526.3M | $108.0M |
| FY2024 | $142.1M | $580.6M | $183.6M |
| FY2025 | $196.0M | $763.6M | $165.6M |